The GZF1 Knockout HAP1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the GZF1 gene. This product offers a heterogeneous pool of HAP1 cells in which the GZF1 locus has been disrupted via CRISPR/Cas9-mediated gene editing, enabling robust functional analysis of GZF1-dependent processes. The polyclonal format allows researchers to interrogate GZF1 biology without clonal selection artifacts, while retaining the advantages of the HAP1 host background.
The HAP1 cell line is a near-haploid human cell line derived from a male chronic myeloid leukemia patient. These fibroblast-like adherent cells are widely employed in functional genomics and genetic screens due to their haploid genome, which eliminates functional compensation by a second allele upon gene disruption. This characteristic renders HAP1 cells an ideal platform for generating knockout models to study gene function, signaling pathways, and disease mechanisms with high reproducibility and ease of genetic manipulation.
GZF1 encodes a GDNF-inducible zinc finger transcription repressor that plays a critical role in neuronal differentiation and cell cycle regulation. GZF1 is activated downstream of the GDNF/Ret receptor signaling axis, where ligand-bound RET triggers intracellular cascades involving MAPK/ERK and AKT kinases. Upon activation, GZF1 translocates to the nucleus and binds to target gene promoters, recruiting co-repressor complexes that include HDAC1 and SIN3A to repress transcription. Notable direct targets of GZF1-mediated repression include CDKN1A (p21), a cyclin-dependent kinase inhibitor, and CCND1 (cyclin D1), a key cell cycle promoter; GZF1 also modulates the pro-apoptotic factor BAX. This transcriptional network links neurotrophic signaling to cell cycle arrest and differentiation.
The knockout of GZF1 in the HAP1 background creates a powerful model for dissecting the molecular mechanisms of GDNF/Ret-dependent gene regulation. Because HAP1 cells are haploid, disruption of the single GZF1 allele eliminates all functional GZF1 protein, avoiding confounding effects from residual wild-type alleles. This model is particularly relevant for investigating the interplay between neurotrophic signaling and cell cycle control, as deregulation of GZF1 has been implicated in neurodevelopmental disorders and cancer. Moreover, the polyclonal nature of the knockout population provides a more physiologically relevant system for high-throughput screening applications.
Researchers can employ GZF1 Knockout HAP1 Polyclonal Cells in a diverse array of assays to elucidate GZF1 function. Applications include neuronal development and neurodegenerative disease modeling, where differentiation assays and immunofluorescence can assess morphological changes upon GZF1 loss. In cancer biology, proliferation assays and western blot analysis of downstream targets like p21 and cyclin D1 reveal alterations in cell cycle progression. Gene regulation studies benefit from ChIP-qPCR and luciferase reporter assays to validate GZF1 promoter occupancy and transcriptional repression. Transcriptomic profiling by RNA-seq further enables global characterization of GZF1-dependent gene networks. For additional information or technical support, please contact Ascent Research.
